首页 > 最新文献

Psychoneuroendocrinology最新文献

英文 中文
Adverse childhood experiences and diurnal cortisol pattern and heart rate variability in adults.
IF 3.4 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-01-18 DOI: 10.1016/j.psyneuen.2025.107359
Mifuyu Akasaki, Andrew Steptoe, Rebecca Hardy

Dysregulation of hypothalamic-pituitary-adrenal axis (HPA axis) and of the autonomic nervous system may link stress throughout the life course with poorer health. This study aims to investigate whether multiple adverse childhood experiences have a long-term impact on markers of these systems - cortisol secretion and heart rate variability - in adulthood. Data were from the Whitehall II cohort study. Fourteen adversities, collected retrospectively in midlife, were considered. Outcomes were total amount of cortisol secretion during the day (area under the curve [AUC]), cortisol awakening response (CAR), and diurnal slope, estimated from six saliva samples taken on a weekday; and resting heart rate (rHR) and heart rate variability (HRV) measured for five minutes at three time points over 10 years with the last measures taken at the same time as the salivary measurement. Regression models were used to examine the association of adversities with AUC, CAR, rHR and HRV and multilevel modelling was applied to analyses of cortisol diurnal slope and the 10-year follow-up of rHR and HRV. At least one early life adversity was reported by 68 % of participants. There was little evidence that increasing number of adversities was associated with any measures of cortisol, rHR or HRV or 10-year change in rHR or HRV. Of the individual adversities, only parental death was associated with increased AUC and CAR. In conclusion, although the HPA axis and autonomic nervous system have been hypothesized as mechanisms relating to adverse childhood experiences with health, our study finds no evidence to support this.

{"title":"Adverse childhood experiences and diurnal cortisol pattern and heart rate variability in adults.","authors":"Mifuyu Akasaki, Andrew Steptoe, Rebecca Hardy","doi":"10.1016/j.psyneuen.2025.107359","DOIUrl":"https://doi.org/10.1016/j.psyneuen.2025.107359","url":null,"abstract":"<p><p>Dysregulation of hypothalamic-pituitary-adrenal axis (HPA axis) and of the autonomic nervous system may link stress throughout the life course with poorer health. This study aims to investigate whether multiple adverse childhood experiences have a long-term impact on markers of these systems - cortisol secretion and heart rate variability - in adulthood. Data were from the Whitehall II cohort study. Fourteen adversities, collected retrospectively in midlife, were considered. Outcomes were total amount of cortisol secretion during the day (area under the curve [AUC]), cortisol awakening response (CAR), and diurnal slope, estimated from six saliva samples taken on a weekday; and resting heart rate (rHR) and heart rate variability (HRV) measured for five minutes at three time points over 10 years with the last measures taken at the same time as the salivary measurement. Regression models were used to examine the association of adversities with AUC, CAR, rHR and HRV and multilevel modelling was applied to analyses of cortisol diurnal slope and the 10-year follow-up of rHR and HRV. At least one early life adversity was reported by 68 % of participants. There was little evidence that increasing number of adversities was associated with any measures of cortisol, rHR or HRV or 10-year change in rHR or HRV. Of the individual adversities, only parental death was associated with increased AUC and CAR. In conclusion, although the HPA axis and autonomic nervous system have been hypothesized as mechanisms relating to adverse childhood experiences with health, our study finds no evidence to support this.</p>","PeriodicalId":20836,"journal":{"name":"Psychoneuroendocrinology","volume":"173 ","pages":"107359"},"PeriodicalIF":3.4,"publicationDate":"2025-01-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143029323","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Melatonin secretion across puberty: A systematic review and meta-analysis. 青春期褪黑激素分泌:一项系统回顾和荟萃分析。
IF 3.4 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-01-11 DOI: 10.1016/j.psyneuen.2025.107281
Christian C Andersen, Eva K R Kjær, Christian B Vase, René Mathiasen, Nanette M Debes, Niklas R Jørgensen, Poul J Jennum

Background: Melatonin levels decrease with aging and substantially during puberty. Studies have presented distinct melatonin levels in patients with disorders related to their pubertal development compared to healthy controls. The discrepancy suggests that a decrease in melatonin concentrations seen during adolescence might be related to the physical, hormonal, and/or neuronal alterations that occur during the pubertal period. The aim of this review was to analyze the literature reporting melatonin levels in healthy children and adolescents during puberty, and to look for a potential relationship.

Methods: The Medline and Embase databases were searched on November 28th 2024, including all articles published from 1974 to 2024. Moreover, in the studies eligible for full-text review, a "snowball" search based by backwards referencing was carried out to identify additional studies. This means going through the references of the eligible studies, to find potential other articles relevant for our review and met our inclusion criteria. Lastly, a meta-analysis on serum melatonin concentrations with increasing age and Tanner status was performed.

Results: 21 studies were included. 12 studies found a decrease, 5 found no difference and 3 reported an increase in melatonin levels during pubertal advancement. One study could not report secretory alterations but was eligible for inclusion in the meta-analysis. This analysis revealed that Tanner stages were significantly associated with decreasing average as well as peak concentrations of melatonin.

Conclusion: The simultaneous occurrence of pubertal progression and chronological aging complicates potential reasons to the decrease observed. However, possible explanations could be related to sex hormones, physical properties of puberty or light exposure. To justify these explanations research in controlled conditions along with biochemical and clinical assessment of pubertal status is needed.

背景:褪黑激素水平随着年龄的增长而下降,在青春期显著下降。研究表明,与健康对照相比,与青春期发育相关的疾病患者的褪黑激素水平明显不同。这一差异表明,青春期褪黑激素浓度的下降可能与青春期发生的身体、激素和/或神经元变化有关。本综述的目的是分析有关青春期健康儿童和青少年褪黑激素水平的文献报道,并寻找两者之间的潜在关系。方法:检索Medline和Embase数据库于2024年11月28日检索1974 - 2024年发表的所有文章。此外,在符合全文综述条件的研究中,进行了基于向后参考的“滚雪球”搜索,以确定其他研究。这意味着要查阅符合条件的研究的参考文献,寻找与我们的综述相关且符合我们的纳入标准的潜在的其他文章。最后,对血清褪黑素浓度随年龄和皮肤状况的增加进行meta分析。结果:共纳入21项研究。12项研究发现褪黑激素水平下降,5项研究发现没有差异,3项研究报告褪黑激素水平在青春期上升。一项研究没有报告分泌改变,但符合纳入荟萃分析的条件。这一分析表明,坦纳阶段与褪黑激素的平均浓度和峰值浓度的下降显著相关。结论:同时发生的青春期的发展和年龄的老化复杂的潜在原因的减少观察。然而,可能的解释可能与性激素、青春期的生理特性或光照有关。为了证明这些解释的合理性,需要在对照条件下进行生化和临床评价青春期状态的研究。
{"title":"Melatonin secretion across puberty: A systematic review and meta-analysis.","authors":"Christian C Andersen, Eva K R Kjær, Christian B Vase, René Mathiasen, Nanette M Debes, Niklas R Jørgensen, Poul J Jennum","doi":"10.1016/j.psyneuen.2025.107281","DOIUrl":"https://doi.org/10.1016/j.psyneuen.2025.107281","url":null,"abstract":"<p><strong>Background: </strong>Melatonin levels decrease with aging and substantially during puberty. Studies have presented distinct melatonin levels in patients with disorders related to their pubertal development compared to healthy controls. The discrepancy suggests that a decrease in melatonin concentrations seen during adolescence might be related to the physical, hormonal, and/or neuronal alterations that occur during the pubertal period. The aim of this review was to analyze the literature reporting melatonin levels in healthy children and adolescents during puberty, and to look for a potential relationship.</p><p><strong>Methods: </strong>The Medline and Embase databases were searched on November 28th 2024, including all articles published from 1974 to 2024. Moreover, in the studies eligible for full-text review, a \"snowball\" search based by backwards referencing was carried out to identify additional studies. This means going through the references of the eligible studies, to find potential other articles relevant for our review and met our inclusion criteria. Lastly, a meta-analysis on serum melatonin concentrations with increasing age and Tanner status was performed.</p><p><strong>Results: </strong>21 studies were included. 12 studies found a decrease, 5 found no difference and 3 reported an increase in melatonin levels during pubertal advancement. One study could not report secretory alterations but was eligible for inclusion in the meta-analysis. This analysis revealed that Tanner stages were significantly associated with decreasing average as well as peak concentrations of melatonin.</p><p><strong>Conclusion: </strong>The simultaneous occurrence of pubertal progression and chronological aging complicates potential reasons to the decrease observed. However, possible explanations could be related to sex hormones, physical properties of puberty or light exposure. To justify these explanations research in controlled conditions along with biochemical and clinical assessment of pubertal status is needed.</p>","PeriodicalId":20836,"journal":{"name":"Psychoneuroendocrinology","volume":"173 ","pages":"107281"},"PeriodicalIF":3.4,"publicationDate":"2025-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143010379","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Empathic stress in the family: Does diurnal cortisol covariation between adolescents and their parents influence adolescent empathic stress in the laboratory? 家庭共情压力:在实验室中,青少年及其父母之间的皮质醇日共变是否影响青少年共情压力?
IF 3.4 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-01-10 DOI: 10.1016/j.psyneuen.2025.107280
Jost Ulrich Blasberg, Philipp Kanske, Veronika Engert

Empathic stress is the reproduction of psychological and physiological stress activation in an observer of a directly stressed target individual. It likely allows us to allocate the energy necessary to jointly alleviate a stressor at hand. The tendency to show such an empathic or "second-hand" stress response depends on the relationship between target and observer. Here, we investigated whether adolescents' empathic stress responses to their parents' acute stress experience were associated with the diurnal cortisol covariation the parent-adolescent dyad shared in everyday life. Fathers and mothers (N = 77) were confronted with a standardized laboratory stressor, the Trier Social Stress Test, while their adolescent children (13-16 years old) were watching. In the laboratory, parents and their adolescent children simultaneously provided multiple samples of salivary cortisol. On the weekend following the testing session, dyads provided diurnal cortisol samples over two days. These were used to gain a measure of the dyads' adrenocortical physiological attunement in everyday life. We found that the degree to which dyads covaried in their diurnal cortisol activity significantly increased adolescents' tendency for empathic stress responding in the laboratory. The amount of time that dyads spent together over the weekend, adolescents' attachment experiences, dyad type (father-daughter, mother-daughter, father-son, mother-son), and adolescents' puberty status did not significantly alter this relationship. Adolescent attachment avoidance, however, was negatively correlated with both adolescents' cortisol stress reactivity in the laboratory and the degree to which they covaried with their parents' diurnal cortisol release. We conclude that diurnal cortisol covariation between parents and adolescents is positively associated with stress resonance in the laboratory.

共情应激是心理和生理应激激活在观察者对直接应激目标个体的再现。它可能会让我们分配必要的能量来共同缓解手头的压力。表现出这种共情或“二手”压力反应的倾向取决于目标和观察者之间的关系。在此,我们调查了青少年对父母急性应激经历的共情应激反应是否与父母-青少年在日常生活中共享的每日皮质醇共变有关。父亲和母亲(N = 77)面对一个标准化的实验室压力源,特里尔社会压力测试,而他们的青少年子女(13-16岁)在观看。在实验室里,父母和他们青春期的孩子同时提供了多种唾液皮质醇样本。在测试结束后的周末,二人组在两天内每天提供皮质醇样本。这些数据被用来测量二人组在日常生活中的肾上腺皮质生理调节。我们发现,在实验室中,二人组在其日常皮质醇活动中共变的程度显著增加了青少年的共情压力反应倾向。二人组在一起度过周末的时间、青少年的依恋经历、二人组类型(父女、母女、父子、母子)和青少年的青春期状态对这种关系没有显著影响。然而,青少年依恋回避与实验室中青少年的皮质醇应激反应以及他们与父母每日皮质醇释放的共变程度呈负相关。我们的结论是,在实验室中,父母和青少年之间的皮质醇昼夜共变与压力共振呈正相关。
{"title":"Empathic stress in the family: Does diurnal cortisol covariation between adolescents and their parents influence adolescent empathic stress in the laboratory?","authors":"Jost Ulrich Blasberg, Philipp Kanske, Veronika Engert","doi":"10.1016/j.psyneuen.2025.107280","DOIUrl":"https://doi.org/10.1016/j.psyneuen.2025.107280","url":null,"abstract":"<p><p>Empathic stress is the reproduction of psychological and physiological stress activation in an observer of a directly stressed target individual. It likely allows us to allocate the energy necessary to jointly alleviate a stressor at hand. The tendency to show such an empathic or \"second-hand\" stress response depends on the relationship between target and observer. Here, we investigated whether adolescents' empathic stress responses to their parents' acute stress experience were associated with the diurnal cortisol covariation the parent-adolescent dyad shared in everyday life. Fathers and mothers (N = 77) were confronted with a standardized laboratory stressor, the Trier Social Stress Test, while their adolescent children (13-16 years old) were watching. In the laboratory, parents and their adolescent children simultaneously provided multiple samples of salivary cortisol. On the weekend following the testing session, dyads provided diurnal cortisol samples over two days. These were used to gain a measure of the dyads' adrenocortical physiological attunement in everyday life. We found that the degree to which dyads covaried in their diurnal cortisol activity significantly increased adolescents' tendency for empathic stress responding in the laboratory. The amount of time that dyads spent together over the weekend, adolescents' attachment experiences, dyad type (father-daughter, mother-daughter, father-son, mother-son), and adolescents' puberty status did not significantly alter this relationship. Adolescent attachment avoidance, however, was negatively correlated with both adolescents' cortisol stress reactivity in the laboratory and the degree to which they covaried with their parents' diurnal cortisol release. We conclude that diurnal cortisol covariation between parents and adolescents is positively associated with stress resonance in the laboratory.</p>","PeriodicalId":20836,"journal":{"name":"Psychoneuroendocrinology","volume":"173 ","pages":"107280"},"PeriodicalIF":3.4,"publicationDate":"2025-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143010374","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transcriptomics study of hippocampus in mice exposed to heat stress. 热应激小鼠海马转录组学研究。
IF 3.4 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-01-04 DOI: 10.1016/j.psyneuen.2025.107279
Bin Li, Longfei Du, Shusheng Wu, Yuye Yin

Heat stress (HS) triggers various pathophysiological responses in the brain, including neuroinflammation and cognitive impairments. The objective of this study was to examine the impact of HS by comparing the hippocampal transcriptomes of mice exposed to HS with those under control conditions. Our analysis revealed that HS exposure did not affect the number of SNP or InDel mutations in the mouse hippocampus, nor did it influence SNP functions, distribution, or types. However, HS did lead to differential gene expression in the hippocampus, with 210 differentially expressed genes (DEGs), including 72 upregulated and 138 downregulated genes. Gene Ontology (GO) analysis indicated that these DEGs are involved in hippocampal responses to various stimuli (chemical, oxygen-containing compounds, peptide hormones), metabolic processes (arachidonic acid, olefinic compound metabolism, lipid metabolism), and other functions. The regulation of these functions may be closely linked to specific DEGs, such as Card14, Ntrk1, Lcn2, Irs4, Cyp2c70, Hamp, Ambp, Gh, Mup19, and others, which exhibit the highest degree of differential variation. Furthermore, we observed that pre-treatment with taurine primarily modulated cognitive functions in the hippocampus following HS. Therefore, our study offers valuable insights for future research on heat stress-induced cognitive impairments and provides a theoretical foundation for developing taurine-based preventive strategies for high-risk populations.

热应激(HS)在大脑中引发各种病理生理反应,包括神经炎症和认知障碍。本研究的目的是通过比较暴露于HS的小鼠与对照组小鼠的海马转录组来研究HS的影响。我们的分析显示,HS暴露不影响小鼠海马中SNP或InDel突变的数量,也不影响SNP的功能、分布或类型。然而,HS确实导致了海马的差异基因表达,有210个差异表达基因(DEGs),其中72个基因上调,138个基因下调。基因本体(Gene Ontology, GO)分析表明,这些deg参与海马对各种刺激(化学、含氧化合物、肽激素)的反应、代谢过程(花生四烯酸、烯烃化合物代谢、脂质代谢)和其他功能。这些功能的调控可能与特定的deg密切相关,如Card14、Ntrk1、Lcn2、Irs4、Cyp2c70、Hamp、Ambp、Gh、Mup19等,它们表现出最大程度的差异变异。此外,我们观察到牛磺酸预处理主要调节HS后海马的认知功能。因此,本研究为今后热应激性认知障碍的研究提供了有价值的见解,并为制定基于牛磺酸的高危人群预防策略提供了理论基础。
{"title":"Transcriptomics study of hippocampus in mice exposed to heat stress.","authors":"Bin Li, Longfei Du, Shusheng Wu, Yuye Yin","doi":"10.1016/j.psyneuen.2025.107279","DOIUrl":"https://doi.org/10.1016/j.psyneuen.2025.107279","url":null,"abstract":"<p><p>Heat stress (HS) triggers various pathophysiological responses in the brain, including neuroinflammation and cognitive impairments. The objective of this study was to examine the impact of HS by comparing the hippocampal transcriptomes of mice exposed to HS with those under control conditions. Our analysis revealed that HS exposure did not affect the number of SNP or InDel mutations in the mouse hippocampus, nor did it influence SNP functions, distribution, or types. However, HS did lead to differential gene expression in the hippocampus, with 210 differentially expressed genes (DEGs), including 72 upregulated and 138 downregulated genes. Gene Ontology (GO) analysis indicated that these DEGs are involved in hippocampal responses to various stimuli (chemical, oxygen-containing compounds, peptide hormones), metabolic processes (arachidonic acid, olefinic compound metabolism, lipid metabolism), and other functions. The regulation of these functions may be closely linked to specific DEGs, such as Card14, Ntrk1, Lcn2, Irs4, Cyp2c70, Hamp, Ambp, Gh, Mup19, and others, which exhibit the highest degree of differential variation. Furthermore, we observed that pre-treatment with taurine primarily modulated cognitive functions in the hippocampus following HS. Therefore, our study offers valuable insights for future research on heat stress-induced cognitive impairments and provides a theoretical foundation for developing taurine-based preventive strategies for high-risk populations.</p>","PeriodicalId":20836,"journal":{"name":"Psychoneuroendocrinology","volume":"172 ","pages":"107279"},"PeriodicalIF":3.4,"publicationDate":"2025-01-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142972056","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cortisol and testosterone coupling: Enhanced hormone reactivity to intercollegiate athletic competition in women athletes. 皮质醇和睾酮耦合:女性运动员对校际体育竞赛的激素反应性增强。
IF 3.4 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-01-04 DOI: 10.1016/j.psyneuen.2025.107278
Filip Durovic, David A Edwards

In a variety of settings, cortisol and testosterone are positively "coupled." That is, within-person fluctuations of these hormones occur in parallel, with increases and decreases in one hormone corresponding to increases and decreases in the other. A dataset comprised of salivary cortisol and testosterone levels from varsity women athletes from six different Emory University sports teams (volleyball 2002, 2005, and 2008; softball 2004; tennis 2009; soccer 2013) was used to explore the relationship between coupling and hormone reactivity to athletic competition. In the majority of athletes, athletic competition was associated with increases in levels of salivary cortisol and testosterone occurring principally during the period between the start of warm-up and the end of competition. Athletes varied with respect to the degree that cortisol and testosterone were coupled. Athletes for whom these two hormones were strongly coupled showed substantially higher competition-related increases in cortisol and testosterone levels than athletes for whom these hormones were less strongly coupled. This heretofore undocumented relationship between hormone coupling and hormone reactivity in a sport setting is consonant with the idea that increases in cortisol and testosterone are parts of a coordinated and complementary response to the physical and/or psychological stress of athletic competition. Given that cortisol and testosterone, each in their own way(s) positively affect athletic performance, a singular benefit of cortisol/testosterone coupling may be an enhanced reactivity to competition, with a corresponding increase in the positive effects of each of these hormones on performance.

在各种情况下,皮质醇和睾丸激素是积极“耦合”的。也就是说,这些激素在人体内的波动是平行发生的,一种激素的增加和减少对应于另一种激素的增加和减少。数据集包括来自埃默里大学六个不同运动队的女运动员的唾液皮质醇和睾丸激素水平(2002年、2005年和2008年排球;垒球2004;网球2009;足球2013)被用来探讨耦合和激素反应性之间的关系,以竞技。在大多数运动员中,体育比赛与唾液皮质醇和睾酮水平的增加有关,主要发生在热身开始和比赛结束之间的这段时间。运动员的皮质醇和睾酮的结合程度各不相同。这两种激素强烈耦合的运动员在比赛中皮质醇和睾丸激素水平的增长明显高于激素不强烈耦合的运动员。在运动环境中,激素偶联和激素反应性之间的关系迄今未被证实,这与皮质醇和睾丸激素的增加是对体育比赛中身体和/或心理压力的协调和互补反应的一部分的观点是一致的。鉴于皮质醇和睾酮都以各自的方式积极影响运动表现,皮质醇/睾酮耦合的一个单一好处可能是增强对竞争的反应性,同时这些激素对表现的积极影响也相应增加。
{"title":"Cortisol and testosterone coupling: Enhanced hormone reactivity to intercollegiate athletic competition in women athletes.","authors":"Filip Durovic, David A Edwards","doi":"10.1016/j.psyneuen.2025.107278","DOIUrl":"https://doi.org/10.1016/j.psyneuen.2025.107278","url":null,"abstract":"<p><p>In a variety of settings, cortisol and testosterone are positively \"coupled.\" That is, within-person fluctuations of these hormones occur in parallel, with increases and decreases in one hormone corresponding to increases and decreases in the other. A dataset comprised of salivary cortisol and testosterone levels from varsity women athletes from six different Emory University sports teams (volleyball 2002, 2005, and 2008; softball 2004; tennis 2009; soccer 2013) was used to explore the relationship between coupling and hormone reactivity to athletic competition. In the majority of athletes, athletic competition was associated with increases in levels of salivary cortisol and testosterone occurring principally during the period between the start of warm-up and the end of competition. Athletes varied with respect to the degree that cortisol and testosterone were coupled. Athletes for whom these two hormones were strongly coupled showed substantially higher competition-related increases in cortisol and testosterone levels than athletes for whom these hormones were less strongly coupled. This heretofore undocumented relationship between hormone coupling and hormone reactivity in a sport setting is consonant with the idea that increases in cortisol and testosterone are parts of a coordinated and complementary response to the physical and/or psychological stress of athletic competition. Given that cortisol and testosterone, each in their own way(s) positively affect athletic performance, a singular benefit of cortisol/testosterone coupling may be an enhanced reactivity to competition, with a corresponding increase in the positive effects of each of these hormones on performance.</p>","PeriodicalId":20836,"journal":{"name":"Psychoneuroendocrinology","volume":"173 ","pages":"107278"},"PeriodicalIF":3.4,"publicationDate":"2025-01-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143010370","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genetic variants in COMT and ESR1 genes shape treatment response to raloxifene in schizophrenia-spectrum disorders. COMT和ESR1基因的遗传变异决定了精神分裂症谱系障碍患者对雷洛昔芬的治疗反应。
IF 3.4 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-01-03 DOI: 10.1016/j.psyneuen.2024.107274
Bodyl A Brand, Anne Jetske Boer, Janna N de Boer, Kiymet Bozaoglu, Kim Morris, Susan Rossell, Iris E C Sommer
<p><strong>Background/objective: </strong>Raloxifene, a selective estrogen receptor modulator (SERM), may improve symptoms and cognition in schizophrenia spectrum disorders (SSD). Studies have shown inconsistent efficacy, especially in men with SSD. We assessed whether single nucleotide polymorphisms (SNPs) on genes involved in the pharmacodynamics (ESR1 and COMT) and pharmacokinetics (UGT1A8) of raloxifene can explain the heterogeneous treatment response to raloxifene augmentation in patients with SSD.</p><p><strong>Methods: </strong>We used a subsample of the participants of a previously published randomized controlled trial (RCT) on the effects of 12-week raloxifene augmentation on symptom severity in SSD. The subsample consisted of 83 participants (28 % female), of which 40 were randomized to receive raloxifene 120 mg/day and 43 to placebo. Saliva samples for DNA-analysis were collected at baseline, symptom severity was measured with the Positive and Negative Syndrome Scale (PANSS). Participants were genotyped for two SNPs on ESR1, one on UGT1A8, and four on COMT using the Agena MassArray system. Linear mixed-effect models were used to assess the effect of treatment-by-genotype as the primary analysis and treatment-by-genotype-by-sex as a secondary analysis.</p><p><strong>Results: </strong>We found interactions of treatment-by-genotype for ESR1 rs2234693 (χ<sup>2</sup> = 6.32, p < 0.05), and COMT rs4818 (χ<sup>2</sup> = 4.08, p < 0.05), indicating that for these polymorphisms, the effect of raloxifene differed per genotype. Pairwise comparisons revealed a beneficial effect of raloxifene on general symptom severity in participants with ESR1 rs2234693 TT genotype but not CT and CC genotypes (LSM -3.19 [95 % CI -6.38-0.00]; p = 0.050). Furthermore, mean change in positive symptom severity was greater with raloxifene in participants with COMT rs4818 CG genotype but not CC genotype compared to placebo (LSM -2.18 [-3.93 to -0.43]; p = 0.016). Secondary sex-specific analysis indicated an interaction effect of treatment-by-genotype-by-sex for COMT rs737865 on total (χ<sup>2</sup> = 10.90, p < 0.05) and negative symptom severity (χ<sup>2</sup> = 11.99, p < 0.05). In men, genotype CT but not TT was associated with beneficial effects of raloxifene on total symptoms (LSM -5.46 [-10.43 to -0.48]; p = 0.032), whereas in women, genotype TT but not CT was associated with a beneficial effect of raloxifene on negative symptoms (LSM -7.80 [-12.70 to -2.89]; p = 0.005).</p><p><strong>Conclusion: </strong>Our results suggest that treatment response to raloxifene may depend on ESR1 and COMT gene variants, while UGT1A8 SNP variation did not affect treatment response. These findings provide evidence that genetic variants may explain the heterogeneous response to raloxifene augmentation in SSD, suggesting that raloxifene may have beneficial effects in genetic subgroups of SSD patients. Our findings warrant further research on the pharmacogenetic effects of raloxifene
背景/目的:雷洛昔芬是一种选择性雌激素受体调节剂(SERM),可能改善精神分裂症谱系障碍(SSD)的症状和认知。研究显示疗效不一致,尤其是对患有SSD的男性。我们评估了与雷洛昔芬药效学(ESR1和COMT)和药代动力学(UGT1A8)相关基因的单核苷酸多态性(snp)是否可以解释SSD患者对雷洛昔芬增加治疗的异质性反应。方法:我们使用了先前发表的随机对照试验(RCT)参与者的子样本,研究了12周雷洛昔芬增加对SSD症状严重程度的影响。亚样本包括83名参与者(28% %女性),其中40人随机接受雷洛昔芬120 mg/天,43人接受安慰剂。基线时采集唾液样本进行dna分析,用阳性和阴性综合征量表(PANSS)测量症状严重程度。使用Agena MassArray系统对参与者进行ESR1上的两个snp, UGT1A8上的一个snp和COMT上的四个snp的基因分型。采用线性混合效应模型评估按基因型处理的效果作为主要分析,按基因型处理的效果作为次要分析。结果:我们发现ESR1 rs2234693基因型治疗的相互作用(χ2 = 6.32, p 2 = 4.08,p 2 = 10.90,p 2 = 11.99,p )结论:我们的结果表明雷洛昔芬的治疗反应可能取决于ESR1和COMT基因的变异,而UGT1A8 SNP变异不影响治疗反应。这些发现提供了遗传变异可以解释SSD患者对雷洛昔芬增加的异质反应的证据,表明雷洛昔芬可能对SSD患者的遗传亚群有有益的影响。我们的发现为进一步研究雷洛昔芬在SSD中的药理学作用提供了依据。
{"title":"Genetic variants in COMT and ESR1 genes shape treatment response to raloxifene in schizophrenia-spectrum disorders.","authors":"Bodyl A Brand, Anne Jetske Boer, Janna N de Boer, Kiymet Bozaoglu, Kim Morris, Susan Rossell, Iris E C Sommer","doi":"10.1016/j.psyneuen.2024.107274","DOIUrl":"https://doi.org/10.1016/j.psyneuen.2024.107274","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background/objective: &lt;/strong&gt;Raloxifene, a selective estrogen receptor modulator (SERM), may improve symptoms and cognition in schizophrenia spectrum disorders (SSD). Studies have shown inconsistent efficacy, especially in men with SSD. We assessed whether single nucleotide polymorphisms (SNPs) on genes involved in the pharmacodynamics (ESR1 and COMT) and pharmacokinetics (UGT1A8) of raloxifene can explain the heterogeneous treatment response to raloxifene augmentation in patients with SSD.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;We used a subsample of the participants of a previously published randomized controlled trial (RCT) on the effects of 12-week raloxifene augmentation on symptom severity in SSD. The subsample consisted of 83 participants (28 % female), of which 40 were randomized to receive raloxifene 120 mg/day and 43 to placebo. Saliva samples for DNA-analysis were collected at baseline, symptom severity was measured with the Positive and Negative Syndrome Scale (PANSS). Participants were genotyped for two SNPs on ESR1, one on UGT1A8, and four on COMT using the Agena MassArray system. Linear mixed-effect models were used to assess the effect of treatment-by-genotype as the primary analysis and treatment-by-genotype-by-sex as a secondary analysis.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;We found interactions of treatment-by-genotype for ESR1 rs2234693 (χ&lt;sup&gt;2&lt;/sup&gt; = 6.32, p &lt; 0.05), and COMT rs4818 (χ&lt;sup&gt;2&lt;/sup&gt; = 4.08, p &lt; 0.05), indicating that for these polymorphisms, the effect of raloxifene differed per genotype. Pairwise comparisons revealed a beneficial effect of raloxifene on general symptom severity in participants with ESR1 rs2234693 TT genotype but not CT and CC genotypes (LSM -3.19 [95 % CI -6.38-0.00]; p = 0.050). Furthermore, mean change in positive symptom severity was greater with raloxifene in participants with COMT rs4818 CG genotype but not CC genotype compared to placebo (LSM -2.18 [-3.93 to -0.43]; p = 0.016). Secondary sex-specific analysis indicated an interaction effect of treatment-by-genotype-by-sex for COMT rs737865 on total (χ&lt;sup&gt;2&lt;/sup&gt; = 10.90, p &lt; 0.05) and negative symptom severity (χ&lt;sup&gt;2&lt;/sup&gt; = 11.99, p &lt; 0.05). In men, genotype CT but not TT was associated with beneficial effects of raloxifene on total symptoms (LSM -5.46 [-10.43 to -0.48]; p = 0.032), whereas in women, genotype TT but not CT was associated with a beneficial effect of raloxifene on negative symptoms (LSM -7.80 [-12.70 to -2.89]; p = 0.005).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;Our results suggest that treatment response to raloxifene may depend on ESR1 and COMT gene variants, while UGT1A8 SNP variation did not affect treatment response. These findings provide evidence that genetic variants may explain the heterogeneous response to raloxifene augmentation in SSD, suggesting that raloxifene may have beneficial effects in genetic subgroups of SSD patients. Our findings warrant further research on the pharmacogenetic effects of raloxifene","PeriodicalId":20836,"journal":{"name":"Psychoneuroendocrinology","volume":"172 ","pages":"107274"},"PeriodicalIF":3.4,"publicationDate":"2025-01-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142972055","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of the medial septum neurotensin receptor 1 in anxiety-like behaviors evoked by emotional stress. 内隔神经紧张素受体1在情绪压力诱发的焦虑样行为中的作用。
IF 3.4 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-01-02 DOI: 10.1016/j.psyneuen.2024.107275
Leilei Chang, Yecheng He, Bin Li

Anxiety is one of the most common mental disorders. Neurotensin (NT) is a neuropeptide widely distributed in the central nervous system, involved in the pathophysiology of many neural and psychiatric disorders such as anxiety. However, the neural substrates mediating NT's effect on the regulation of anxiety have not been fully identified. The medial septum (MS) is a crucial brain region in regulating anxiety and expresses neurotensin receptor 1 (NTS1). In the current study, we examined the role of NT/NTS1 in the MS on the anxiety-like behaviors of rats in non-stress and acute stress conditions. We reported that intra-MS infusion of NT produced remarkable anxiogenic effect in behavioral tests. The anxiogenic effect could be blocked by NTS1 antagonist SR48692 pretreatment. Microinjection of NTS1 antagonist to block endogenously released NT in the MS had no effect on anxiety-like behaviors in non-stressed rats, but significantly reduced anxiety in acute restraint stressed rats. Moreover, molecular knockdown of NTS1 in the MS ameliorated anxiety induced by acute restraint stress, also confirming the pharmacological results. Our study implicates NT and its receptors as potential targets for therapeutic interventions of psychiatric diseases, such as anxiety.

焦虑是最常见的精神障碍之一。神经紧张素(NT)是一种广泛分布于中枢神经系统的神经肽,参与许多神经和精神疾病的病理生理,如焦虑。然而,介导NT对焦虑调节作用的神经基质尚未完全确定。内侧间隔(MS)是调节焦虑和表达神经紧张素受体1 (NTS1)的关键脑区。在本研究中,我们研究了MS中NT/NTS1在非应激和急性应激条件下对大鼠焦虑样行为的作用。我们报道ms内灌注NT在行为测试中产生显著的焦虑效应。NTS1拮抗剂SR48692预处理可阻断其致焦虑作用。显微注射NTS1拮抗剂阻断MS内源性释放的NT对非应激大鼠的焦虑样行为无影响,但显著降低急性约束应激大鼠的焦虑。此外,MS中NTS1的分子敲低可以改善急性约束应激引起的焦虑,也证实了药理学结果。我们的研究暗示NT及其受体是治疗精神疾病(如焦虑)的潜在靶点。
{"title":"Role of the medial septum neurotensin receptor 1 in anxiety-like behaviors evoked by emotional stress.","authors":"Leilei Chang, Yecheng He, Bin Li","doi":"10.1016/j.psyneuen.2024.107275","DOIUrl":"https://doi.org/10.1016/j.psyneuen.2024.107275","url":null,"abstract":"<p><p>Anxiety is one of the most common mental disorders. Neurotensin (NT) is a neuropeptide widely distributed in the central nervous system, involved in the pathophysiology of many neural and psychiatric disorders such as anxiety. However, the neural substrates mediating NT's effect on the regulation of anxiety have not been fully identified. The medial septum (MS) is a crucial brain region in regulating anxiety and expresses neurotensin receptor 1 (NTS1). In the current study, we examined the role of NT/NTS1 in the MS on the anxiety-like behaviors of rats in non-stress and acute stress conditions. We reported that intra-MS infusion of NT produced remarkable anxiogenic effect in behavioral tests. The anxiogenic effect could be blocked by NTS1 antagonist SR48692 pretreatment. Microinjection of NTS1 antagonist to block endogenously released NT in the MS had no effect on anxiety-like behaviors in non-stressed rats, but significantly reduced anxiety in acute restraint stressed rats. Moreover, molecular knockdown of NTS1 in the MS ameliorated anxiety induced by acute restraint stress, also confirming the pharmacological results. Our study implicates NT and its receptors as potential targets for therapeutic interventions of psychiatric diseases, such as anxiety.</p>","PeriodicalId":20836,"journal":{"name":"Psychoneuroendocrinology","volume":"172 ","pages":"107275"},"PeriodicalIF":3.4,"publicationDate":"2025-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142954006","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Maternal pre- and postnatal stress and maternal and infant gut microbiota features. 产妇产前和产后应激与母婴肠道菌群特征。
IF 3.4 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-01-02 DOI: 10.1016/j.psyneuen.2024.107273
Henrik Eckermann, Hellen Lustermans, Katariina Parnanen, Leo Lahti, Carolina de Weerth

Background: Maternal stress can have short and long term adverse (mental) health effects for the mother and her child. Previous evidence suggests that the gut microbiota may be a potential mediator and moderator for the effects of stress via various pathways. This study explored the maternal microbiota trajectory during pregnancy as well as the association between pre- and postnatal maternal stress and features of the maternal and infant gut microbiota during and after pregnancy. In line with previous research, we hypothesized that maternal stress would be positively related to maternal and infant microbiota volatility and that infants of highly stressed mothers would show a relative increase in Proteobacteria and a relative decrease in Bifidobacterium.

Methods: We collected maternal stool samples at 18 and 32 weeks of pregnancy and 8 months postpartum. Infant stools samples were obtained at 2, 6 and 12 weeks and 8 months postpartum. All samples were analyzed using shotgun metagenome sequencing. We also collected several measures of maternal stress (self-reported depression, anxiety, and stress, and hair cortisol and cortisone), most at the same time points as the microbiota samples.

Results: Our data indicated that the maternal microbiota does not undergo drastic changes from the second to the third trimester of pregnancy but that the postpartum microbiota differs significantly from the prenatal microbiota. Furthermore, we identified associations between several stress measures and maternal and infant gut microbiota features at different time points including positive and negative associations with alpha diversity, beta diversity and individual microbial phyla and species relative abundances. Also, the maternal stress composite score, the perceived stress score and the log-ratio of hair cortisol and cortisone were all positively associated with infant microbiota volatility.

Conclusion: Our study provides evidence that maternal prenatal and postnatal stress is related to both the maternal and the infant microbiota. Collectively, this and previous studies indicate that maternal stress does not uniformly associate with most gut microbial features. Instead, the associations are highly time point specific. Regarding infant microbiota volatility, we have consistently found a positive association between stress and infant microbiota volatility. This warrants future research investigating this link in more depth.

背景:母性压力会对母婴产生短期和长期的不良(心理)健康影响。以往的证据表明,肠道微生物群可能是通过各种途径产生压力效应的潜在媒介和调节因子。本研究探讨了孕期母体微生物群的变化轨迹,以及产前和产后母体压力与孕期和产后母婴肠道微生物群特征之间的关联。与之前的研究一致,我们假设母体压力与母婴微生物群的波动呈正相关,高度压力母亲的婴儿会表现出蛋白菌的相对增加和双歧杆菌的相对减少:我们收集了母亲在怀孕 18 周和 32 周以及产后 8 个月的粪便样本。在怀孕 2、6 和 12 周以及产后 8 个月时采集了婴儿粪便样本。所有样本均采用枪式元基因组测序法进行分析。我们还收集了几种衡量产妇压力的指标(自我报告的抑郁、焦虑和压力,以及毛发皮质醇和可的松),大部分与微生物群样本在同一时间点采集:结果:我们的数据表明,从怀孕的第二个三个月到第三个三个月,母体微生物群不会发生剧烈变化,但产后微生物群与产前微生物群有很大不同。此外,我们还发现了几种压力测量指标与不同时间点母婴肠道微生物群特征之间的关联,包括与α多样性、β多样性和单个微生物门类及物种相对丰度之间的正负关联。此外,母体压力综合得分、感知压力得分以及毛发皮质醇和可的松的对数比值都与婴儿微生物群的波动性呈正相关:我们的研究提供的证据表明,母体产前和产后压力与母体和婴儿微生物群有关。总之,本研究和以往的研究表明,母体压力与大多数肠道微生物特征的关系并不一致。相反,这种关联具有高度的时间点特异性。关于婴儿微生物群的波动性,我们一直发现压力与婴儿微生物群的波动性呈正相关。这就需要未来的研究更深入地调查这种联系。
{"title":"Maternal pre- and postnatal stress and maternal and infant gut microbiota features.","authors":"Henrik Eckermann, Hellen Lustermans, Katariina Parnanen, Leo Lahti, Carolina de Weerth","doi":"10.1016/j.psyneuen.2024.107273","DOIUrl":"https://doi.org/10.1016/j.psyneuen.2024.107273","url":null,"abstract":"<p><strong>Background: </strong>Maternal stress can have short and long term adverse (mental) health effects for the mother and her child. Previous evidence suggests that the gut microbiota may be a potential mediator and moderator for the effects of stress via various pathways. This study explored the maternal microbiota trajectory during pregnancy as well as the association between pre- and postnatal maternal stress and features of the maternal and infant gut microbiota during and after pregnancy. In line with previous research, we hypothesized that maternal stress would be positively related to maternal and infant microbiota volatility and that infants of highly stressed mothers would show a relative increase in Proteobacteria and a relative decrease in Bifidobacterium.</p><p><strong>Methods: </strong>We collected maternal stool samples at 18 and 32 weeks of pregnancy and 8 months postpartum. Infant stools samples were obtained at 2, 6 and 12 weeks and 8 months postpartum. All samples were analyzed using shotgun metagenome sequencing. We also collected several measures of maternal stress (self-reported depression, anxiety, and stress, and hair cortisol and cortisone), most at the same time points as the microbiota samples.</p><p><strong>Results: </strong>Our data indicated that the maternal microbiota does not undergo drastic changes from the second to the third trimester of pregnancy but that the postpartum microbiota differs significantly from the prenatal microbiota. Furthermore, we identified associations between several stress measures and maternal and infant gut microbiota features at different time points including positive and negative associations with alpha diversity, beta diversity and individual microbial phyla and species relative abundances. Also, the maternal stress composite score, the perceived stress score and the log-ratio of hair cortisol and cortisone were all positively associated with infant microbiota volatility.</p><p><strong>Conclusion: </strong>Our study provides evidence that maternal prenatal and postnatal stress is related to both the maternal and the infant microbiota. Collectively, this and previous studies indicate that maternal stress does not uniformly associate with most gut microbial features. Instead, the associations are highly time point specific. Regarding infant microbiota volatility, we have consistently found a positive association between stress and infant microbiota volatility. This warrants future research investigating this link in more depth.</p>","PeriodicalId":20836,"journal":{"name":"Psychoneuroendocrinology","volume":"172 ","pages":"107273"},"PeriodicalIF":3.4,"publicationDate":"2025-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142965691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Linking childhood allostatic load, early adversity and the emergence of mental health symptoms in early adulthood: Analysis of the ALSPAC longitudinal birth cohort. 儿童适应负荷、早期逆境和成年早期心理健康症状的出现:ALSPAC纵向出生队列的分析
IF 3.4 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-12-31 DOI: 10.1016/j.psyneuen.2024.107276
Sabine Finlay, Oyelola Adegboye, Brett McDermott, Donna Rudd, Zoltán Sarnyai

Background: It has been well-established that the allostatic load (AL) index, a cumulative score of multi-system dysregulation in response to chronic stress, is significantly increased at the time of a psychiatric diagnosis. However, no studies have investigated if there is an association between the AL index in childhood and the later development of mental health symptoms in young adults.

Methods: Using data from the Avon Longitudinal Study of Parents and Children (ALSPAC), a population cohort from Bristol, United Kingdom, we investigated the AL index at age 9 years and the risks for mental health symptoms at age 24 years. We used multinomial logistic regression analysis to investigate the association between AL threshold (categorised into bottom third: AL index ≤ 7, middle third: AL index = 7.1-9.9, and top third: AL index ≥ 10) and mental health symptoms while adjusting for sex, the age of mother at delivery, and social class. We used a relative risk ratio (RRR) and 95 % confidence interval(CI) for each variable. We further investigated the association between adverse childhood experiences (ACEs) and mental health symptoms.

Results: We identified a significant association between sex and mental health symptoms, with more females (59 % vs 41 %) showing mental health symptoms than males. We found no direct association between the AL index at age 9 and the later development of mental health symptoms. However, an RRR analysis showed that individuals in the middle and the top third of the AL index had an RRR of 1.99 and 2.20, respectively, to develop mental health symptoms if they were females. We found that individuals who experienced ACE had a much higher risk of developing mental health symptoms as young adults, with the adjusted RRR of 5.39 (95 % CI: 3.00;9.67), 6.79 (95 % CI: 2.55; 18.1), and 2.10 (95 % CI: 0.37;11.8) for neglect, physical and sexual abuse, respectively, in individuals with mood disorder symptoms. The adjusted RRR for neglect and physical and sexual abuse in individuals with psychotic symptoms was 0.99 (95 % CI: 0.37; 2.59), 2.92 (95 % CI: 0.35; 24.4), and 10.5 (95 % CI: 0.99; 112), respectively.

Conclusion: Although the AL index in childhood was not directly associated with the later development of psychotic and mood disorder symptoms in this cohort, females in the higher tertiles of the AL index measured at 9 years of age had an elevated risk of mental health symptoms as young adults. In line with previous work, a strong association was identified between childhood adversity and mental health symptoms in young adulthood. These results highlight the importance of considering the impact of early stress on biological embedding and the later emergence of mental health problems, especially in females.

背景:已经证实,在精神病诊断时,适应负荷(AL)指数,即对慢性应激反应的多系统失调的累积评分,显著增加。然而,目前还没有研究调查儿童时期的AL指数与年轻成人后期心理健康症状的发展之间是否存在关联。方法:使用来自英国布里斯托尔的雅芳父母与儿童纵向研究(ALSPAC)的人口队列数据,我们调查了9岁时的AL指数和24岁时心理健康症状的风险。我们采用多项逻辑回归分析,在调整性别、分娩母亲年龄和社会阶层后,探讨AL阈值(分为AL指数≤7的后三分之一、AL指数= 7.1-9.9的中三分之一和AL指数≥10的前三分之一)与心理健康症状之间的关系。我们对每个变量使用了相对风险比(RRR)和95% %置信区间(CI)。我们进一步调查了不良童年经历(ace)与心理健康症状之间的关系。结果:我们确定了性别与心理健康症状之间的显著关联,女性(59 % vs 41 %)比男性更多地表现出心理健康症状。我们发现9岁时的AL指数与后来的心理健康症状发展之间没有直接联系。然而,一项RRR分析显示,如果是女性,在AL指数的中间和前三分之一的个体出现心理健康症状的RRR分别为1.99和2.20。我们发现,经历过ACE的个体在年轻时出现精神健康症状的风险要高得多,调整后的RRR为5.39(95 % CI: 3.00;9.67), 6.79(95 % CI: 2.55;在有情绪障碍症状的个体中,忽视、身体虐待和性虐待分别为18.1)和2.10(95 % CI: 0.37;11.8)。在有精神病症状的个体中,忽视、身体虐待和性虐待的调整RRR为0.99(95 % CI: 0.37;2.59), 2.92(95 % ci: 0.35;24.4)和10.5(95 % CI: 0.99;分别为112)。结论:尽管在该队列中,儿童时期的AL指数与精神病和情绪障碍症状的后期发展没有直接关系,但在9岁时测量的AL指数较高的女性在年轻成人时出现精神健康症状的风险较高。与之前的研究一致,儿童时期的逆境与成年后的心理健康症状之间存在很强的联系。这些结果强调了考虑早期压力对生物嵌入和后来出现的心理健康问题的影响的重要性,特别是在女性中。
{"title":"Linking childhood allostatic load, early adversity and the emergence of mental health symptoms in early adulthood: Analysis of the ALSPAC longitudinal birth cohort.","authors":"Sabine Finlay, Oyelola Adegboye, Brett McDermott, Donna Rudd, Zoltán Sarnyai","doi":"10.1016/j.psyneuen.2024.107276","DOIUrl":"https://doi.org/10.1016/j.psyneuen.2024.107276","url":null,"abstract":"<p><strong>Background: </strong>It has been well-established that the allostatic load (AL) index, a cumulative score of multi-system dysregulation in response to chronic stress, is significantly increased at the time of a psychiatric diagnosis. However, no studies have investigated if there is an association between the AL index in childhood and the later development of mental health symptoms in young adults.</p><p><strong>Methods: </strong>Using data from the Avon Longitudinal Study of Parents and Children (ALSPAC), a population cohort from Bristol, United Kingdom, we investigated the AL index at age 9 years and the risks for mental health symptoms at age 24 years. We used multinomial logistic regression analysis to investigate the association between AL threshold (categorised into bottom third: AL index ≤ 7, middle third: AL index = 7.1-9.9, and top third: AL index ≥ 10) and mental health symptoms while adjusting for sex, the age of mother at delivery, and social class. We used a relative risk ratio (RRR) and 95 % confidence interval(CI) for each variable. We further investigated the association between adverse childhood experiences (ACEs) and mental health symptoms.</p><p><strong>Results: </strong>We identified a significant association between sex and mental health symptoms, with more females (59 % vs 41 %) showing mental health symptoms than males. We found no direct association between the AL index at age 9 and the later development of mental health symptoms. However, an RRR analysis showed that individuals in the middle and the top third of the AL index had an RRR of 1.99 and 2.20, respectively, to develop mental health symptoms if they were females. We found that individuals who experienced ACE had a much higher risk of developing mental health symptoms as young adults, with the adjusted RRR of 5.39 (95 % CI: 3.00;9.67), 6.79 (95 % CI: 2.55; 18.1), and 2.10 (95 % CI: 0.37;11.8) for neglect, physical and sexual abuse, respectively, in individuals with mood disorder symptoms. The adjusted RRR for neglect and physical and sexual abuse in individuals with psychotic symptoms was 0.99 (95 % CI: 0.37; 2.59), 2.92 (95 % CI: 0.35; 24.4), and 10.5 (95 % CI: 0.99; 112), respectively.</p><p><strong>Conclusion: </strong>Although the AL index in childhood was not directly associated with the later development of psychotic and mood disorder symptoms in this cohort, females in the higher tertiles of the AL index measured at 9 years of age had an elevated risk of mental health symptoms as young adults. In line with previous work, a strong association was identified between childhood adversity and mental health symptoms in young adulthood. These results highlight the importance of considering the impact of early stress on biological embedding and the later emergence of mental health problems, especially in females.</p>","PeriodicalId":20836,"journal":{"name":"Psychoneuroendocrinology","volume":"172 ","pages":"107276"},"PeriodicalIF":3.4,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142954005","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cortisol and C-reactive protein (CRP) regulation in severe mental disorders. 严重精神障碍患者皮质醇和c反应蛋白(CRP)的调节。
IF 3.4 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-12-25 DOI: 10.1016/j.psyneuen.2024.107272
Amina Inova, Viktoria Birkenæs, Daniel S Quintana, Monica B E G Ormerod, Torill Ueland, Thor Ueland, Srdjan Djurovic, Ole Andreassen, Nils Eiel Steen, Monica Aas

Background: People with schizophrenia (SZ) and bipolar disorder (BD) show abnormalities in the biological stress system and low-grade inflammation. However, whether the hypothalamic-pituitary-adrenal (HPA) axis-immune regulation is disrupted in SZ and BD, is yet to be determined.

Methods: Cortisol and C-reactive protein (CRP) were measured in blood samples collected at or before 10 am in participants with SZ (N = 257), BD (N = 153), and healthy controls (N = 40). Cortisol/CRP ratio was calculated as an indicator of the balance between HPA axis activity and inflammatory activity, called HPA axis-immune regulation. Global functioning and symptom levels were obtained using the Global Assessment of Functioning (GAF) Scale and Positive and Negative Syndrome Scale (PANSS). Standardized neuropsychological tests were used to assess cognitive function. All analyses were adjusted for demographic variables (age and sex) and the time of blood sampling.

Results: Participants with a SZ or BD diagnosis had lower cortisol/CRP ratios (F=5.93, p = 0.003) compared to healthy controls. The difference was no longer statistically significant (p > 0.1) when BMI was added as a covariate to the model. Within patients, those on psychotropic treatment (n = 337) had lower cortisol/CRP ratio than those not taking psychotropic agents (n = 59) (F=4.72, p = 0.03). Compared to HC, only patients on regular psychotropic agents had lower cortisol/CRP ratio (p = 0.02). Within the SZ group, lower cortisol/CRP ratio was associated with having poorer general functioning as measured by GAF (ß=-0.18, p = 0.01), and more severe negative and general symptomatology as measured by PANSS (ß=0.19, p = 0.007 and ß=0.18, p = 0.01, respectively). In SZ, lower cortisol/CRP ratio was also associated with poorer verbal memory, learning, and processing speed (ß=-0.20 p = 0.007, ß=-0.19 p = 0.01, ß=-0.25, p > 0.001, respectively). No associations were observed between cortisol/CRP ratio and clinical and cognitive functioning in the BD group.

Conclusion: These findings may indicate HPA axis-immune dysregulation in SZ. Our study further indicates that disrupted HPA axis-immune regulation in people with SZ and BD is associated with psychotropic treatment and fat mass, highlighting the clinical importance of weight control and regular psychotropic treatment follow-ups within this group.

背景:精神分裂症(SZ)和双相情感障碍(BD)患者表现为生物应激系统异常和低度炎症。然而,在SZ和BD中,下丘脑-垂体-肾上腺(HPA)轴-免疫调节是否被破坏尚不清楚。方法:对SZ (N = 257)、BD (N = 153)和健康对照(N = 40)患者在10:00 am或之前采集的血液样本进行皮质醇和c反应蛋白(CRP)的检测。计算皮质醇/CRP比率作为HPA轴活性与炎症活性之间平衡的指标,称为HPA轴-免疫调节。使用整体功能评估量表(GAF)和阳性和阴性综合征量表(PANSS)获得整体功能和症状水平。采用标准化神经心理学测试评估认知功能。所有的分析都根据人口统计学变量(年龄和性别)和抽血时间进行了调整。结果:与健康对照组相比,诊断为SZ或BD的参与者皮质醇/CRP比率较低(F=5.93, p = 0.003)。当将BMI作为协变量添加到模型中时,差异不再具有统计学意义(p > 0.1)。在患者中,接受精神药物治疗的患者(n = 337)的皮质醇/CRP比值低于未服用精神药物的患者(n = 59)(F=4.72, p = 0.03)。与HC相比,只有服用常规精神药物的患者皮质醇/CRP比值较低(p = 0.02)。在SZ组中,较低的皮质醇/CRP比值与GAF测量的较差的一般功能(ß=-0.18, p = 0.01)和PANSS测量的更严重的阴性和一般症状(ß=0.19, p = 0.007和ß=0.18, p = 0.01)相关。在SZ,较低的皮质醇/CRP比值也与较差的言语记忆、学习和处理速度相关(ß=-0.20 p = 0.007,ß=-0.19 p = 0.01,ß=-0.25, p > 0.001)。在BD组中,皮质醇/CRP比值与临床和认知功能之间没有关联。结论:这些结果可能提示SZ的HPA轴免疫失调。我们的研究进一步表明,SZ和BD患者的HPA轴免疫调节紊乱与精神药物治疗和脂肪量有关,强调了该组体重控制和定期精神药物治疗随访的临床重要性。
{"title":"Cortisol and C-reactive protein (CRP) regulation in severe mental disorders.","authors":"Amina Inova, Viktoria Birkenæs, Daniel S Quintana, Monica B E G Ormerod, Torill Ueland, Thor Ueland, Srdjan Djurovic, Ole Andreassen, Nils Eiel Steen, Monica Aas","doi":"10.1016/j.psyneuen.2024.107272","DOIUrl":"https://doi.org/10.1016/j.psyneuen.2024.107272","url":null,"abstract":"<p><strong>Background: </strong>People with schizophrenia (SZ) and bipolar disorder (BD) show abnormalities in the biological stress system and low-grade inflammation. However, whether the hypothalamic-pituitary-adrenal (HPA) axis-immune regulation is disrupted in SZ and BD, is yet to be determined.</p><p><strong>Methods: </strong>Cortisol and C-reactive protein (CRP) were measured in blood samples collected at or before 10 am in participants with SZ (N = 257), BD (N = 153), and healthy controls (N = 40). Cortisol/CRP ratio was calculated as an indicator of the balance between HPA axis activity and inflammatory activity, called HPA axis-immune regulation. Global functioning and symptom levels were obtained using the Global Assessment of Functioning (GAF) Scale and Positive and Negative Syndrome Scale (PANSS). Standardized neuropsychological tests were used to assess cognitive function. All analyses were adjusted for demographic variables (age and sex) and the time of blood sampling.</p><p><strong>Results: </strong>Participants with a SZ or BD diagnosis had lower cortisol/CRP ratios (F=5.93, p = 0.003) compared to healthy controls. The difference was no longer statistically significant (p > 0.1) when BMI was added as a covariate to the model. Within patients, those on psychotropic treatment (n = 337) had lower cortisol/CRP ratio than those not taking psychotropic agents (n = 59) (F=4.72, p = 0.03). Compared to HC, only patients on regular psychotropic agents had lower cortisol/CRP ratio (p = 0.02). Within the SZ group, lower cortisol/CRP ratio was associated with having poorer general functioning as measured by GAF (ß=-0.18, p = 0.01), and more severe negative and general symptomatology as measured by PANSS (ß=0.19, p = 0.007 and ß=0.18, p = 0.01, respectively). In SZ, lower cortisol/CRP ratio was also associated with poorer verbal memory, learning, and processing speed (ß=-0.20 p = 0.007, ß=-0.19 p = 0.01, ß=-0.25, p > 0.001, respectively). No associations were observed between cortisol/CRP ratio and clinical and cognitive functioning in the BD group.</p><p><strong>Conclusion: </strong>These findings may indicate HPA axis-immune dysregulation in SZ. Our study further indicates that disrupted HPA axis-immune regulation in people with SZ and BD is associated with psychotropic treatment and fat mass, highlighting the clinical importance of weight control and regular psychotropic treatment follow-ups within this group.</p>","PeriodicalId":20836,"journal":{"name":"Psychoneuroendocrinology","volume":"172 ","pages":"107272"},"PeriodicalIF":3.4,"publicationDate":"2024-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142910410","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Psychoneuroendocrinology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1